<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36389825</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>HLA-DR3 restricted environmental epitopes from the bacterium <i>Clostridium tetani</i> have T cell cross-reactivity to the SLE-related autoantigen SmD.</ArticleTitle><Pagination><StartPage>928374</StartPage><MedlinePgn>928374</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">928374</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.928374</ELocationID><Abstract><AbstractText>HLA-DR3 (DR3) is one of the dominant HLA-DR alleles associated with systemic lupus erythematosus (SLE) susceptibility. Our previous studies showed multiple intramolecular DR3 restricted T cell epitopes in the Smith D (SmD) protein, from which we generated a non-homologous, bacterial epitope mimics library. From this library we identified ABC<sub>247-261</sub> Mimic as one new DR3 restricted bacterial T cell epitope from the ABC transporter ATP-binding protein in <i>Clostridium tetani</i>. It activated and induced autoreactive SmD<sub>66-80</sub>-specific T cells and induced autoantibodies to lupus-related autoantigens <i>in vivo</i>. Compared to healthy donors, SLE patients have a greater percentage of cross-reactive T cells to ABC<sub>247-261</sub> Mimic and SmD<sub>66-80</sub>. In addition, we analyzed the ability of single DR3 restricted Tetanus toxoid (TT) T cell epitopes to induce autoimmune T cells. We found that the immunodominant TT epitope TT<sub>826-845</sub> stimulated SmD<sub>66-80</sub> reactive T cells but failed to induce persistent anti-SmD autoantibodies compared to the ABC<sub>247-261</sub> Mimic. Thus, exposure to the ABC<sub>247-261</sub> Mimic epitope may contribute to autoimmunity in susceptible DR3 individuals.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Zhao, Anderson, Kannapell, Kwok, Gaskin and Fu.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Zhenhuan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, University of Virginia, Charlottesville, VA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Immunity, Inflammation and Regenerative Medicine, Division of Nephrology, Department of Medicine, University of Virginia, Charlottesville, VA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Ashley N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Center for Immunity, Inflammation and Regenerative Medicine, Division of Nephrology, Department of Medicine, University of Virginia, Charlottesville, VA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kannapell</LastName><ForeName>Carol C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, University of Virginia, Charlottesville, VA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Immunity, Inflammation and Regenerative Medicine, Division of Nephrology, Department of Medicine, University of Virginia, Charlottesville, VA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwok</LastName><ForeName>William W</ForeName><Initials>WW</Initials><AffiliationInfo><Affiliation>Benaroya Research Institute, Virginia Mason, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaskin</LastName><ForeName>Felicia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Shu Man</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, University of Virginia, Charlottesville, VA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Immunity, Inflammation and Regenerative Medicine, Division of Nephrology, Department of Medicine, University of Virginia, Charlottesville, VA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>TL1 DK132771</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U2C DK129500</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 DK072922</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI139673</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015803">HLA-DR3 Antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001324">Autoantigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018984">Epitopes, T-Lymphocyte</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015803" MajorTopicYN="Y">HLA-DR3 Antigen</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001324" MajorTopicYN="N">Autoantigens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003017" MajorTopicYN="N">Clostridium tetani</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018984" MajorTopicYN="N">Epitopes, T-Lymphocyte</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HLA-DR3</Keyword><Keyword MajorTopicYN="N">Smith D (SmD)</Keyword><Keyword MajorTopicYN="N">T cell epitope</Keyword><Keyword MajorTopicYN="N">autoantigen</Keyword><Keyword MajorTopicYN="N">cross-reactive T cells</Keyword><Keyword MajorTopicYN="N">environmental bacteria</Keyword><Keyword MajorTopicYN="N">molecular mimicry</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus (SLE)</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>17</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36389825</ArticleId><ArticleId IdType="pmc">PMC9659850</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.928374</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tsokos GC. Systemic lupus erythematosus. New Engl J Med (2011) 365(22):2110&#x2013;21. doi:&#xa0;10.1056/nejmra1100359</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmra1100359</ArticleId><ArticleId IdType="pubmed">22129255</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. . Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med (2003) 349(16):1526&#x2013;33. doi:&#xa0;10.1056/NEJMoa021933</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa021933</ArticleId><ArticleId IdType="pubmed">14561795</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy K, Weaver C. Chapter 15: Autoimmunity and transplantation. In: Janeway's immunobiology, 9th ed. New York, NY: Garland Science/Taylor &amp; Francis Group, LLC; (2016). p. 676.</Citation></Reference><Reference><Citation>Fu SM, Deshmukh US, Gaskin F. Pathogenesis of systemic lupus erythematosus revisited 2011: end organ resistance to damage, autoantibody initiation and diversification, and HLA-DR. J Autoimmun (2011) 37(2):104&#x2013;12. doi:&#xa0;10.1016/j.jaut.2011.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2011.05.004</ArticleId><ArticleId IdType="pmc">PMC3173577</ArticleId><ArticleId IdType="pubmed">21632208</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang C, Deshmukh US, Gaskin F, Bagavant H, Hanson J, David CS, et al. . Differential responses to smith d autoantigen by mice with HLA-DR and HLA-DQ transgenes: dominant responses by HLA-DR3 transgenic mice with diversification of autoantibodies to small nuclear ribonucleoprotein, double-stranded DNA, and nuclear antigens. J Immunol (Baltimore Md 1950) (2010) 184(2):1085&#x2013;91. doi:&#xa0;10.4049/jimmunol.0902670</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0902670</ArticleId><ArticleId IdType="pmc">PMC2842881</ArticleId><ArticleId IdType="pubmed">20007529</ArticleId></ArticleIdList></Reference><Reference><Citation>Cusick MF, Libbey JE, Fujinami RS. Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol (2012) 42(1):102&#x2013;11. doi:&#xa0;10.1007/s12016-011-8294-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-011-8294-7</ArticleId><ArticleId IdType="pmc">PMC3266166</ArticleId><ArticleId IdType="pubmed">22095454</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshmukh US, Sim DL, Dai C, Kannapell CJ, Gaskin F, Rajagopalan G, et al. . HLA-DR3 restricted T cell epitope mimicry in induction of autoimmune response to lupus-associated antigen SmD. J Autoimmun (2011) 37(3):254&#x2013;62. doi:&#xa0;10.1016/j.jaut.2011.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2011.07.002</ArticleId><ArticleId IdType="pmc">PMC3372418</ArticleId><ArticleId IdType="pubmed">21868195</ArticleId></ArticleIdList></Reference><Reference><Citation>Szymula A, Rosenthal J, Szczerba BM, Bagavant H, Fu SM, Deshmukh US. T Cell epitope mimicry between sj&#xf6;gren's syndrome antigen a (SSA)/Ro60 and oral, gut, skin and vaginal bacteria. Clin Immunol (Orlando Fla) (2014) 152(1-2):1&#x2013;9. doi:&#xa0;10.1016/j.clim.2014.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2014.02.004</ArticleId><ArticleId IdType="pmc">PMC4004658</ArticleId><ArticleId IdType="pubmed">24576620</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z, Ren J, Dai C, Kannapell CC, Wang H, Gaskin F, et al. . Nature of T cell epitopes in lupus antigens and HLA-DR determines autoantibody initiation and diversification. Ann Rheum Dis (2019) 78(3):380&#x2013;90. doi:&#xa0;10.1136/annrheumdis-2018-214125</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2018-214125</ArticleId><ArticleId IdType="pmc">PMC6377330</ArticleId><ArticleId IdType="pubmed">30254034</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. . 2019 European League against Rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol (2019) 71(9):1400&#x2013;12. doi:&#xa0;10.1002/art.40930</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40930</ArticleId><ArticleId IdType="pmc">PMC6827566</ArticleId><ArticleId IdType="pubmed">31385462</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunce M. PCR-sequence-specific primer typing of HLA class I and class II alleles. Methods Mol Biol (2003) 210:143&#x2013;71. doi:&#xa0;10.1385/1-59259-291-0:143</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/1-59259-291-0:143</ArticleId><ArticleId IdType="pubmed">12412454</ArticleId></ArticleIdList></Reference><Reference><Citation>Flynn J, Gorry P. Flow cytometry analysis to identify human CD4+ T cell subsets. New York: Springer; (2019) p. 15&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">31396925</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak EJ, Liu AW, Nepom GT, Kwok WW. MHC class II tetramers identify peptide-specific human CD4+ T cells proliferating in response to influenza a antigen. J Clin Invest (1999) 104(12):R63&#x2013;R7. doi:&#xa0;10.1172/jci8476</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci8476</ArticleId><ArticleId IdType="pmc">PMC480919</ArticleId><ArticleId IdType="pubmed">10606632</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshmukh US, Lewis JE, Gaskin F, Kannapell CC, Waters ST, Lou YH, et al. . Immune responses to Ro60 and its peptides in mice. i. the nature of the immunogen and endogenous autoantigen determine the specificities of the induced autoantibodies. J Exp Med (1999) 189(3):531&#x2013;40. doi:&#xa0;10.1084/jem.189.3.531</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.189.3.531</ArticleId><ArticleId IdType="pmc">PMC2192918</ArticleId><ArticleId IdType="pubmed">9927515</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshmukh US, Kannapell CC, Fu SM. Immune responses to small nuclear ribonucleoproteins: Antigen-dependent distinct b cell epitope spreading patterns in mice immunized with recombinant polypeptides of small nuclear ribonucleoproteins. J Immunol (2002) 168(10):5326&#x2013;32. doi:&#xa0;10.4049/jimmunol.168.10.5326</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.168.10.5326</ArticleId><ArticleId IdType="pubmed">11994491</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong YC, Lomo LC, Motte RW, Giraldo AA, Baisch J, Strauss G, et al. . HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene. J Exp Med (1996) 184(3):1167&#x2013;72. doi:&#xa0;10.1084/jem.184.3.1167</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.184.3.1167</ArticleId><ArticleId IdType="pmc">PMC2192804</ArticleId><ArticleId IdType="pubmed">9064334</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruisbeek AM. Production of mouse T cell hybridomas. Curr Protoc Immunol (2001) 24:3.14.1&#x2013;11. doi:&#xa0;10.1002/0471142735.im0314s24. Chapter 3:Unit 3.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471142735.im0314s24</ArticleId><ArticleId IdType="pubmed">18432780</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Silva Antunes R, Paul S, Sidney J, Weiskopf D, Dan JM, Phillips E, et al. . Definition of human epitopes recognized in tetanus toxoid and development of an assay strategy to detect ex vivo tetanus CD4+ T cell responses. PloS One (2017) 12(1):e0169086. doi:&#xa0;10.1371/journal.pone.0169086</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0169086</ArticleId><ArticleId IdType="pmc">PMC5230748</ArticleId><ArticleId IdType="pubmed">28081174</ArticleId></ArticleIdList></Reference><Reference><Citation>James EA, Bui J, Berger D, Huston L, Roti M, Kwok WW. Tetramer-guided epitope mapping reveals broad, individualized repertoires of tetanus toxin-specific CD4+ T cells and suggests HLA-based differences in epitope recognition. Int Immunol (2007) 19(11):1291&#x2013;301. doi:&#xa0;10.1093/intimm/dxm099</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxm099</ArticleId><ArticleId IdType="pubmed">17906339</ArticleId></ArticleIdList></Reference><Reference><Citation>Wienhold W, Malcherek G, Jung C, Stevanovic S, Jung G, Schild H, et al. . An example of immunodominance: engagement of synonymous TCR by invariant CDR3&#x3b2;. Int Immunol (2000) 12(6):747&#x2013;56. doi:&#xa0;10.1093/intimm/12.6.747</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/12.6.747</ArticleId><ArticleId IdType="pubmed">10837402</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruhrman-Shahar N, Torres-Ruiz J, Rotman-Pikielny P, Levy Y. Autoimmune reaction after anti-tetanus vaccination&#x2013;description of four cases and review of the literature. Immunol Res (2017) 65(1):157&#x2013;63. doi:&#xa0;10.1007/s12026-016-8822-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-016-8822-x</ArticleId><ArticleId IdType="pubmed">27435706</ArticleId></ArticleIdList></Reference><Reference><Citation>Wi&#x119;sik-Szewczyk E, Romanowska M, Mielnik P, Chwali&#x144;ska-Sadowska H, Brydak LB, Olesi&#x144;ska M, et al. . Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety. Clin Rheumatol (2010) 29(6):605&#x2013;13. doi:&#xa0;10.1007/s10067-010-1373-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-010-1373-y</ArticleId><ArticleId IdType="pubmed">20140692</ArticleId></ArticleIdList></Reference><Reference><Citation>Agmon-Levin N, Zafrir Y, Paz Z, Shilton T, Zandman-Goddard G, Shoenfeld Y. Ten cases of systemic lupus erythematosus related to hepatitis b vaccine. Lupus (2009) 18(13):1192&#x2013;7. doi:&#xa0;10.1177/0961203309345732</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203309345732</ArticleId><ArticleId IdType="pubmed">19880567</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerstner C, Turcinov S, Hensvold AH, Chemin K, Uchtenhagen H, Ramwadhdoebe TH, et al. . Multi-HLA class II tetramer analyses of citrulline-reactive T cells and early treatment response in rheumatoid arthritis. BMC Immunol (2020) 21(1):1&#x2013;14. doi:&#xa0;10.1186/s12865-020-00357-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12865-020-00357-w</ArticleId><ArticleId IdType="pmc">PMC7236297</ArticleId><ArticleId IdType="pubmed">32423478</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruff WE, Dehner C, Kim WJ, Pagovich O, Aguiar CL, Yu AT, et al. . Pathogenic autoreactive T and b cells cross-react with mimotopes expressed by a common human gut commensal to trigger autoimmunity. Cell Host Microbe (2019) 26(1):100&#x2013;13.e8. doi:&#xa0;10.1016/j.chom.2019.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2019.05.003</ArticleId><ArticleId IdType="pmc">PMC8194364</ArticleId><ArticleId IdType="pubmed">31227334</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Jing L, James EA, Gebe JA, Koelle DM, Kwok WW. A novel approach of identifying immunodominant self and viral antigen cross-reactive T cells and defining the epitopes they recognize. Front Immunol (2018) 9:2811. doi:&#xa0;10.3389/fimmu.2018.02811</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02811</ArticleId><ArticleId IdType="pmc">PMC6298415</ArticleId><ArticleId IdType="pubmed">30619245</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Heemst J, Jansen DTSL, Polydorides S, Moustakas AK, Bax M, Feitsma AL, et al. . Crossreactivity to vinculin and microbes provides a molecular basis for HLA-based protection against rheumatoid arthritis. Nat Commun (2015) 6(1):6681. doi:&#xa0;10.1038/ncomms7681</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7681</ArticleId><ArticleId IdType="pubmed">25942574</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds CJ, Sim MJW, Quigley KJ, Altmann DM, Boyton RJ. Autoantigen cross-reactive environmental antigen can trigger multiple sclerosis-like disease. J Neuroinflamm (2015) 12(1):91. doi:&#xa0;10.1186/s12974-015-0313-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-015-0313-9</ArticleId><ArticleId IdType="pmc">PMC4432996</ArticleId><ArticleId IdType="pubmed">25962509</ArticleId></ArticleIdList></Reference><Reference><Citation>Han A, Newell EW, Glanville J, Fernandez-Becker N, Khosla C, Chien YH, et al. . Dietary gluten triggers concomitant activation of CD4+ and CD8+ &#x3b1;&#x3b2; T cells and &#x3b3;&#x3b4; T cells in celiac disease. Proc Natl Acad Sci USA (2013) 110(32):13073&#x2013;8. doi:&#xa0;10.1073/pnas.1311861110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1311861110</ArticleId><ArticleId IdType="pmc">PMC3740842</ArticleId><ArticleId IdType="pubmed">23878218</ArticleId></ArticleIdList></Reference><Reference><Citation>Massilamany C, Steffen D, Reddy J. An epitope from acanthamoeba castellanii that cross-react with proteolipid protein 139-151-reactive T cells induces autoimmune encephalomyelitis in SJL mice. J Neuroimmunol (2010) 219(1-2):17&#x2013;24. doi:&#xa0;10.1016/j.jneuroim.2009.11.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2009.11.006</ArticleId><ArticleId IdType="pubmed">20005578</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou D, Mitchell LA, Metzger DL, Gillam S, Tingle AJ. Cross-reactive rubella virus and glutamic acid decarboxylase (65 and 67) protein determinants recognised by T cells of patients with type I diabetes mellitus. Diabetologia (2000) 43(6):750&#x2013;62. doi:&#xa0;10.1007/s001250051373</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001250051373</ArticleId><ArticleId IdType="pubmed">10907121</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbot PJ, Paquette J-SB, Ciurli C, Antel JP, Ouellet F. Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis. Ann Neurol (1996) 39(2):233&#x2013;40. doi:&#xa0;10.1002/ana.410390213</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410390213</ArticleId><ArticleId IdType="pmc">PMC7159680</ArticleId><ArticleId IdType="pubmed">8967755</ArticleId></ArticleIdList></Reference><Reference><Citation>Greiling TM, Dehner C, Chen X, Hughes K, I&#xf1;iguez AJ, Boccitto M, et al. . Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus. Sci Trans Med (2018) 10(434):eaan2306. doi:&#xa0;10.1126/scitranslmed.aan2306</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aan2306</ArticleId><ArticleId IdType="pmc">PMC5918293</ArticleId><ArticleId IdType="pubmed">29593104</ArticleId></ArticleIdList></Reference><Reference><Citation>Kattah NH, Newell EW, Jarrell JA, Chu AD, Xie J, Kattah MG, et al. . Tetramers reveal IL-17-secreting CD4+ T cells that are specific for U1-70 in lupus and mixed connective tissue disease. Proc Natl Acad Sci USA (2015) 112(10):3044&#x2013;9. doi:&#xa0;10.1073/pnas.1424796112</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1424796112</ArticleId><ArticleId IdType="pmc">PMC4364210</ArticleId><ArticleId IdType="pubmed">25713364</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard ML, Gilkeson G. Mouse models of lupus: what they tell us and what they don't. Lupus Sci Med (2018) 5(1):e000199. doi:&#xa0;10.1136/lupus-2016-000199</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2016-000199</ArticleId><ArticleId IdType="pmc">PMC5786947</ArticleId><ArticleId IdType="pubmed">29387435</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuldt NJ, Binstadt BA. Dual TCR T cells: Identity crisis or multitaskers? J Immunol (2019) 202(3):637&#x2013;44. doi:&#xa0;10.4049/jimmunol.1800904</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1800904</ArticleId><ArticleId IdType="pubmed">30670579</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Danke NA, Berger D, Reichstetter S, Reijonen H, Greenbaum C, et al. . Islet-specific glucose-6-Phosphatase catalytic subunit-related protein-reactive CD4+ T cells in human subjects. J Immunol (2006) 176(5):2781&#x2013;9. doi:&#xa0;10.4049/jimmunol.176.5.2781</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.176.5.2781</ArticleId><ArticleId IdType="pubmed">16493034</ArticleId></ArticleIdList></Reference><Reference><Citation>Csuka D, Czirj&#xe1;k L, H&#xf3;bor R, Illes Z, B&#xe1;n&#xe1;ti M, Rajczy K, et al. . Effective humoral immunity against diphtheria and tetanus in patients with systemic lupus erythematosus or myasthenia gravis. Mol Immunol (2013) 54(3-4):453&#x2013;6. doi:&#xa0;10.1016/j.molimm.2013.01.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2013.01.012</ArticleId><ArticleId IdType="pubmed">23454161</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashef S, Ghazizadeh F, Derakhshan A, Farjadian S, Alyasin S. Antigen-specific antibody response in juvenile-onset SLE patients following routine immunization with tetanus toxoid. Iran J Immunol (2008) 5(3):181&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">18791286</ArticleId></ArticleIdList></Reference><Reference><Citation>Devey ME, Bleasdale K, Isenberg DA. Antibody affinity and IgG subclass of responses to tetanus toxoid in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol (1987) 68(3):562&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1542762</ArticleId><ArticleId IdType="pubmed">3652524</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhary VR, Dai C, Tilahun AY, Hanson JA, Smart MK, Grande JP, et al. . A central role for HLA-DR3 in anti-smith antibody responses and glomerulonephritis in a transgenic mouse model of spontaneous lupus. J Immunol (Baltimore Md 1950) (2015) 195(10):4660&#x2013;7. doi:&#xa0;10.4049/jimmunol.1501073</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1501073</ArticleId><ArticleId IdType="pmc">PMC5292932</ArticleId><ArticleId IdType="pubmed">26475924</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>